Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

A new study describes a molecular mechanism that could drive the design of strategies to eliminate senescent cells in cancer ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

Z526- a novel dithiocarbamate-like compound reverses cancer associated cachexia via mitigating NF-B signaling and oxidative ...